Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart
Clinical trial NCT07275060 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07275060
- Sponsor
- Canadian Immunization Research Network
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-14
- Primary completion
- 2027-02-28
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.